NCT00216593: Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study |
|
|
| Completed | 3 | 415 | Europe | galantamine hydrobromide | Janssen Pharmaceutica N.V., Belgium | Dementia, Alzheimer Disease | 09/07 | 03/08 | | |
| Completed | 3 | 39 | US | Razadyne, Galantamine, Placebo | Massachusetts General Hospital, Ortho-McNeil Janssen Scientific Affairs, LLC | Major Depression, Bipolar Depression, Schizoaffective Disorder | 01/08 | 01/08 | | |